Stocktoria
SAB Biotherapeutics, Inc. SABS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-01-12
SAB Biotherapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 3,095,197 | $11.6M |
| TWO SIGMA INVESTMENTS, LP | 181,185 | $693,939 |
| CITADEL ADVISORS LLC | 69,600 | $266,568 |
| BlackRock Finance, Inc. | 13,752 | $42,631 |
Source: SEC EDGAR filings · CIK 0001833214 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.